Selenomethionine in the inhibition of a transplantable murine lymphoma: Reflection on hepatic drug metabolizing enzymes

Tumor Biology

Volumn 17, Issue 2, 1996, Pages 102-109

  Rana, Mukti Pada ^a   Sardar, Sutapa ^a   Chatterjee, Malay ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Drug metabolism, hepatic; Selenium

Indexed keywords

LIVER ENZYME; SELENOMETHIONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; LYMPHOMA; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029873157     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000217973     Document Type: Article

References (25)

1. Cowgill VM: The distribution of selenium and cancer mortality in the continental United States. Biol Trace Elem Res 1983;5:345-361.
2. Salonen JT: Senenium in cardiovascular diseases and cancer. Epidemiologic findings from Finland; in Bostrom H, Ljungstedt N (eds): Skandia International Symposium -Trace Elements in Health and Disease. Stockholm, Norstcdts. 1985. pp 182-183.
3. Combs GF. Combs SB: Selenium effects on drug and foreign compound toxicity. Pharmacol Ther 1987:33: 303-316
4. Wendel A, Otter R: Alterations in the intermediary metabolism of selenium deficient mice. Biochim Bio-physActa 1987;925:94-100.
5. Daoud AH, Grif TAC: Effects of selenium and retinoic acid on the metabolism of N-acctylaminofluorine and N-hydroxyacetylamino-fluorine. Cancer Lett 1978:5:231 -237.
6. Herfeld A, Greengard O: The effect of lymphoma and other neoplasms on hepatic and plasma enzymes of the host rat. Cancer Res 1977:37: 231-238.
7. Laws J, Latshaw J, Biggert M: Selenium bioavailability in foods and feeds. Nutr Rep lnt 1986:33:13-24.
8. Goldie H, Felix MD: Growth characteristics of free tumour cells transferred serially in the peritoneal fluid of mouse. Cancer Res 1951; 11:72-80.
9. Rana MP, Ghosh R, Chatterjec M: Changes in tissue levels of glutathione extent of lipid peroxidation and activity of glutathione peroxidase in transplantable murine lymphoma. Oncology 1994;51:25-29.
10. Ornura T, Sato N: The carbon monoxide-binding pigment of liver nti-crosomes. J Biol Client 1964,239: 2370-2378.
11. Williams CH, Kamin H: Microsomal triphosphopyridinc nucleotide -Cytochrome c reductase of liver. J Biol Chem 1962;237:587-595.
12. Habig WH, Pabst MI, Jacoby WB: Glutathione S-transferase: The first enzymatic step in mercapturic acid formation. J Biol Chem 1975:249: 7130-7139.
13. Andersson T, Pensonen M, Johansson C: Differential induction of cytochrome P-450 dependent monooxygenase, epoxide hydrolase, glutathione transferase and UDP glucuronyl transferase activities in the liver of the rainbow trout by β-naphthoflavone or clophen A 50. Biochem Pharmacol 1985:34:3309- 3314.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
15. Sarkar A, Mukherjee B, Chatterjec M: Inhibitory effect of B-carotene on chronic 2-acetylaminofluorinc induced hepatocarcinogenesis in rat: Reflection in hepatic drug metabolism. Carcinogenesis 1994:15:1055- 1060.
16. WHO: International Programme on Chemical Safety Document; Environment Health Criteria. Selenium, Geneva. WHO. 1987, vol 58. pp 214-221.
17. Medina D, Obortt CJ: Differential effects of selenium on the growth of mouse mammary cells in vitro. Cancer Lett 1981;13:333-344.
18. Thompson HJ, Becci PJ: Selenium inhibition of N-methyl-N-nitroso-urea-induccd mammary carcinogenesis in the rat. J Natl Cancer Inst 1980;65:1299-1301.
19. Guengcrich FP: Role of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res 1988;48:2949-2954.
20. Ghazarian JB, Jefcoate CR, Knutson JC, Orme Johnson WH, Deluca HF: Mitochondial cytochrome P-450. A component of chick kidney 25-hydroxycholecalciferol 1-hydroxylase. J Biol Chem 1974:249: 3026-3033.
21. Bock KW, Lilierblum W, Pfeil H, Eriksson LC: Increased uridine diphosphate glucuronyltransfcrasc activity in preneoplastic liver nodules and Morris hepatomas. Cancer Res 1982;42:3747-3752.
22. Wattenberg LW: Inhibition of carcinogenesis by naturally occurring and synthetic compounds: in Antimutagenesis and anticarcinogenesis. New York. Plenum. 1990. vol 2.
23. Talalay P, Batzinger RP, Benson AM, Bueding E, Cha YN: Biochemical studies on the mechanism by which drug antioxidants suppress mutagenic acitivity. Adv Enzyme Regul 1979;17:23-26.
24. Moorghen M, Cairns J, Forrester LM, Hayes AH, Cattan AR, Wolf CR. Harris AL: Enhanced expression of glutathione S-transferase in colorectal carcinoma compared to non-neoplastic mucosa. Carcinogenesis 1991;12:13-17.
25. Oberlcy LW, Buettner GR: Role of superoxide dismutase in cancer: A review. Cancer Res 1979:39:1141-1149.